Evolus (EOLS) Other Non Operating Income (2017 - 2026)
Evolus' (EOLS) quarterly Other Non Operating Income came in at $120000.0 in Q1 2026, up 110.53% YoY from $57000.0 in Q1 2025, and up 1100.0% on a QoQ basis from $10000.0 in Q4 2025.
Evolus (EOLS) Other Non Operating Income (2017 - 2026) Analysis & Trends
Evolus (EOLS) has 10 years of Other Non Operating Income data on file, last reported at $120000.0 in Q1 2026.
- Quarterly Other Non Operating Income rose 110.53% year-over-year to $120000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$476000.0 (down 442.45% YoY) and the FY2025 annual result came in at -$539000.0, down 524.41% from the prior year.
- Other Non Operating Income advanced to $120000.0 in Q1 2026, from $10000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $694000.0 in Q4 2023 to a low of -$455000.0 in Q3 2025.
- A 5-year average of $23235.3 and a median of $19000.0 in 2023 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2023 — Other Non Operating Income sank 442.86% — and 2024, when it soared 1200.0%.
- Tracing EOLS's Other Non Operating Income over 5 years: stood at $84000.0 in 2022, then surged by 726.19% to $694000.0 in 2023, then plunged by 136.46% to -$253000.0 in 2024, then surged by 103.95% to $10000.0 in 2025, then soared by 1100.0% to $120000.0 in 2026.
- The last three Other Non Operating Income figures came in at $120000.0 (Q1 2026), $10000.0 (Q4 2025), and -$455000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Evolus | 554.46 Mn | 509.29 Mn | 57.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 213,000.00 |
| Mar 31, 2026 | 120,000.00 |
| Dec 31, 2025 | 10,000.00 |
| Sep 30, 2025 | -455,000.00 |
| Jun 30, 2025 | -151,000.00 |
| Mar 31, 2025 | 57,000.00 |
| Dec 31, 2024 | -253,000.00 |
| Sep 30, 2024 | 273,000.00 |
| Jun 30, 2024 | 62,000.00 |
| Mar 31, 2024 | 45,000.00 |
| Dec 31, 2023 | 694,000.00 |
| Sep 30, 2023 | 21,000.00 |
| Jun 30, 2023 | 19,000.00 |
| Mar 31, 2023 | -38,000.00 |
| Dec 31, 2022 | 84,000.00 |
| Sep 30, 2022 | -62,000.00 |
| Jun 30, 2022 | -24,000.00 |
| Mar 31, 2022 | -7,000.00 |
| Mar 31, 2021 | 971,000.00 |
| Dec 31, 2020 | -2.82 Mn |